CENTOGENE - transforming genetic data into medical decisions. We are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives us a unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications.
We focus exclusively on providing the highest quality, patient-centred service, verified by multiple international accreditations (ISO, CAP, CLIA), regular pharmaceutical audits and our outstanding short turn-around times for analysis. We believe our medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Our mutation database (CentoMD®) is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. CENTOGENE is a key partner for many high-profile pharmaceutical companies who are active in the orphan drug development.
Location: United Arab Emirates, Dubai
Employees: 501-1000
Phone: +49 381 80113416
Total raised: $28.02M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | TVM Capita... | tvm-lifesc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.06.2017 | Series A | $28.02M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 02.07.2023 | Lifera and CENTOGENE, Enter Strategic Collaboration - Formin... | Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera... | en.prnasia... |
| 19.04.2023 | Startup Showcase: Centogene – Revolutionizing the Diagnosis ... | Centogene is a leading genetic biotech company that provides innovative methods and technology for h... | eustartup.... |
| 06.10.2022 | CENTOGENE to Participate in Upcoming Partnering Conferences ... | CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. ... | globenewsw... |
| 04.01.2022 | CENTOGENE's CentoCloud® Set to Revolutionize Rare Disease Di... | The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laborato... | marketscre... |
| 04.01.2022 | Centogene N : CentoCloud® Set to Revolutionize Rare Disease ... | CENTOGENE's CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralized SaaS Platfo... | marketscre... |
| 24.11.2021 | Centogene N : Reports Third Quarter 2021 Financial Results -... | CENTOGENE Reports Third Quarter 2021 Financial Results Second Consecutive Quarter of Core Business G... | marketscre... |
| 04.11.2021 | CENTOGENE Expands Partnership With Agios to Generate Novel I... | CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases Providi... | marketscre... |
| 07.06.2021 | CENTOGENE N.V. Centogene N : Announces Virtual Investor Eve... | CENTOGENE Announces Virtual Investor Event New leadership team to present vision, strategy, and exec... | marketscre... |
| 03.09.2020 | CENTOGENE : Publishes Huge Dataset that Supports Genome Sequ... | DGAP-News: Centogene NV / Key word(s): Scientific publication CENTOGENE Publishes Huge Dataset that ... | marketscre... |
| 29.10.2019 | CENTOGENE Announces Proposed Initial Public Offering of Comm... | October 28, 2019 at 8:53 AM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIR... | tvm-lifesc... |
Show more